Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP505065.RA5Y7tdUYo_tuBCjuf0ZDqzSIxIXk5RaQTM4pf_jg9NDo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP505065.RA5Y7tdUYo_tuBCjuf0ZDqzSIxIXk5RaQTM4pf_jg9NDo130_assertion type Assertion NP505065.RA5Y7tdUYo_tuBCjuf0ZDqzSIxIXk5RaQTM4pf_jg9NDo130_head.
- NP505065.RA5Y7tdUYo_tuBCjuf0ZDqzSIxIXk5RaQTM4pf_jg9NDo130_assertion description "[Immunoreactivity of all meningiomas was distinctly less intense, however, than that of the human breast cancer cell line SK-BR-3, and slightly lower than that of brain metastases of breast and ovarian carcinomas that served as positive controls for both methods.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505065.RA5Y7tdUYo_tuBCjuf0ZDqzSIxIXk5RaQTM4pf_jg9NDo130_provenance.
- NP505065.RA5Y7tdUYo_tuBCjuf0ZDqzSIxIXk5RaQTM4pf_jg9NDo130_assertion evidence source_evidence_literature NP505065.RA5Y7tdUYo_tuBCjuf0ZDqzSIxIXk5RaQTM4pf_jg9NDo130_provenance.
- NP505065.RA5Y7tdUYo_tuBCjuf0ZDqzSIxIXk5RaQTM4pf_jg9NDo130_assertion SIO_000772 7906070 NP505065.RA5Y7tdUYo_tuBCjuf0ZDqzSIxIXk5RaQTM4pf_jg9NDo130_provenance.
- NP505065.RA5Y7tdUYo_tuBCjuf0ZDqzSIxIXk5RaQTM4pf_jg9NDo130_assertion wasDerivedFrom befree-20140225 NP505065.RA5Y7tdUYo_tuBCjuf0ZDqzSIxIXk5RaQTM4pf_jg9NDo130_provenance.
- NP505065.RA5Y7tdUYo_tuBCjuf0ZDqzSIxIXk5RaQTM4pf_jg9NDo130_assertion wasGeneratedBy ECO_0000203 NP505065.RA5Y7tdUYo_tuBCjuf0ZDqzSIxIXk5RaQTM4pf_jg9NDo130_provenance.